The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060

Diabet Med. 2002 Jul:19 Suppl 4:1-5. doi: 10.1046/j.1464-5491.19.s4.2.x.

Abstract

Aims/hypothesis: To predict the incidence and prevalence of Type 2 diabetes in the UK, the trends in the levels of diabetes-related complications, and the associated health care costs for the period 2000-60.

Methods: An established epidemiological and economic model of the long-term complications and health care costs of Type 2 diabetes was applied to UK population projections from 2000 to 2060. The model was used to calculate the incidence and prevalence of Type 2 diabetes, the caseloads and population burden for diabetes-related complications, and annual NHS health care costs for Type 2 diabetes over this time period.

Results: The total UK population will not increase by more than 3% at any time in the next 60 years. However, the population over 30 will increase by a maximum of 11% by 2030. Due to population ageing, in 2036 there will be approximately 20% more cases of Type 2 diabetes than in 2000. Cases of diabetes-related complications will increase rapidly to peak 20-30% above present levels between 2035 and 2045, before showing a modest decline. The cost of health care for patients with Type 2 diabetes rises by up to 25% during this period, but because of reductions in the economically active age groups, the relative economic burden of the disease can be expected to increase by 40-50%.

Conclusion/interpretation: In the next 30 years Type 2 diabetes will present a serious clinical and financial challenge to the UK NHS.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cost of Illness*
  • Diabetes Mellitus, Type 2 / economics*
  • Diabetes Mellitus, Type 2 / epidemiology*
  • Female
  • Forecasting
  • Health Care Costs / trends*
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Models, Econometric*
  • Morbidity
  • Population Dynamics
  • Prevalence
  • State Medicine / economics*
  • State Medicine / trends
  • United Kingdom / epidemiology